This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n5http://linked.opendata.cz/resource/drugbank/drug/DB07311/identifier/chemspider/
n12http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07311/identifier/pdb/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/resource/drugbank/drug/DB07311/identifier/pubchem-compound/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07311/identifier/pubchem-substance/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB07311/identifier/drugbank/

Statements

Subject Item
n2:DB07311
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n12:DB07311 n13:DB07311
dcterms:title
18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE
adms:identifier
n5:9523569 n7:11348631 n8:99443782 n9:DB07311 n10:A25
n3:IUPAC-Name
n6:271B5EED-363D-11E5-9242-09173F13E4C5
n3:InChI
n6:271B5EF3-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n6:271B5EF2-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n6:271B5EEF-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n6:271B5EF0-363D-11E5-9242-09173F13E4C5
n3:SMILES
n6:271B5EF1-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n6:271B5EEB-363D-11E5-9242-09173F13E4C5
n3:logP
n6:271B5EE9-363D-11E5-9242-09173F13E4C5 n6:271B5EEC-363D-11E5-9242-09173F13E4C5
n3:logS
n6:271B5EEA-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n6:271B5EF9-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n6:271B5EFA-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n6:271B5EF4-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n6:271B5EF5-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n6:271B5EF7-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n6:271B5EF6-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n6:271B5EF8-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n6:271B5EFF-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n6:271B5F01-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n6:271B5F02-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n6:271B5EFE-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n6:271B5EFD-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n6:271B5F00-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n6:271B5EEE-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n6:271B5EFB-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n6:271B5EFC-363D-11E5-9242-09173F13E4C5